相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heparin 2.0: A New Approach to the Infection Crisis
Malin-Theres Seffer et al.
BLOOD PURIFICATION (2021)
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
Massimo Mattioli et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations
Julia A. Tree et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation
Eleonora Maretti et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2021)
Molecular Targeting of VEGF with a Suramin Fragment-DOCA Conjugate by Mimicking the Action of Low Molecular Weight Heparins
Jooho Park et al.
BIOMOLECULES (2021)
Tumor microenvironment-responsive PEGylated heparin-pyropheophorbide-a nanoconjugates for photodynamic therapy`
Yahui Wu et al.
CARBOHYDRATE POLYMERS (2021)
Review: Inhibitory potential of low molecular weight Heparin in cell adhesion; emphasis on tumor metastasis
Umer Ejaz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
Aikaterini Berdiaki et al.
BIOMOLECULES (2021)
Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
Osamu Kumano et al.
BIOMEDICINES (2021)
Updates in Anticoagulation Therapy Monitoring
Hannah L. McRae et al.
BIOMEDICINES (2021)
Preparation and Evaluation of a Self-Nanoemulsifying Drug Delivery System Loaded with Heparin Phospholipid Complex
Xiao-Lei Qiu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
Panagiotis Sarantis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects
Jeong Uk Choi et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
Ritesh Tandon et al.
JOURNAL OF VIROLOGY (2021)
Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
Helene Helfer et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2020)
The preparation of pH and GSH dual responsive thiolated heparin/DOX complex and its application as drug carrier
Juan Wen et al.
CARBOHYDRATE POLYMERS (2020)
Novel N-acetyl-Glycol-split heparin biotin-conjugates endowed with anti-heparanase activity
Emiliano Esposito et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Poly(ε-caprolactone)/keratin/heparin/VEGF biocomposite mats for vascular tissue engineering
Xiuzhen Wan et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2020)
Chemoenzymatic synthesis of ultralow and low-molecular weight heparins
Ting Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives
Noemi Veraldi et al.
MOLECULES (2020)
Self-Propelled Gemini-like LMWH-Scaffold Nanodrugs for Overall Tumor Microenvironment Manipulation via Macrophage Reprogramming and Vessel Normalization
Cheng Xu et al.
NANO LETTERS (2020)
Novel pH-triggered biocompatible polymeric micelles based on heparin-α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer
Jaber Emami et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2020)
Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
Alexandros Bokas et al.
CANCERS (2020)
Advanced delivery strategies facilitating oral absorption of heparins
Guihua Fang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Redox-Responsive Heparin-Chlorambucil Conjugate Polymeric Prodrug for Improved Anti-Tumor Activity
Abegaz Tizazu Andrgie et al.
POLYMERS (2020)
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
Sophie Testa et al.
INTERNAL AND EMERGENCY MEDICINE (2020)
The versatile heparin in COVID-19
Jecko Thachil
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
The association between treatment with heparin and survival in patients with Covid-19
Luis Ayerbe et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer
Robert Hoffmann et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Murine cellular model of mucopolysaccharidosis, type IIIB (MPS IIIB) - A preliminary study with particular emphasis on the non-oxidative L-cysteine metabolism
Marta Kaczor-Kaminska et al.
BIOCHIMIE (2020)
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro
Paul S. Kwon et al.
CELL DISCOVERY (2020)
Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy
Amit Kumar Rajora et al.
PHARMACEUTICS (2020)
Preparation and Application of Nanosensor in Safeguarding Heparin Supply Chain
Yiling Bi et al.
SLAS TECHNOLOGY (2020)
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
So Young Kim et al.
ANTIVIRAL RESEARCH (2020)
Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment
Valeria De Pasquale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Anticoagulant and Nonanticoagulant Properties of Heparin
Danielle M. H. Beurskens et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
Luca Costanzo et al.
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2020)
Characterization, bioactivity and pharmacokinetic study of a novel carbohydrate-peptide polymer: Glycol-split heparin-endostatin2 (GSHP-ES2)
Feng Sun et al.
CARBOHYDRATE POLYMERS (2019)
Non-Anticoagulant Heparin Prodrug Loaded Biodegradable and Injectable Thermoresponsive Hydrogels for Enhanced Anti-Metastasis Therapy
Abegaz Tizazu Andrgie et al.
MACROMOLECULAR BIOSCIENCE (2019)
Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545
Naphak Modhiran et al.
ANTIVIRAL RESEARCH (2019)
The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing
Jun Ishihara et al.
BLOOD (2019)
Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria
Muhammad Ismail et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
The non-anticoagulant promise of heparin and its mimetics
Barbara Mulloy
CURRENT OPINION IN PHARMACOLOGY (2019)
LMWH and its derivatives represent new rational for cancer therapy: construction strategies and combination therapy
Shi Du et al.
DRUG DISCOVERY TODAY (2019)
Inhibition of Inflammation-Associated Thrombosis with ROS-Responsive Heparin-DOCA/PVAX Nanoparticles
Zehong Xiang et al.
MACROMOLECULAR BIOSCIENCE (2019)
Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism
Waldemar E. Wysokinski et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
The utilization of low molecular weight heparin-poloxamer associated Laponite nanoplatform for safe and efficient tumor therapy
Jinyu Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Natural Polysaccharide Nanomaterials: An Overview of Their Immunological Properties
Fernando G. Torres et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The AIB1siRNA-loaded hyaluronic acid-assembled PEI/heparin/Ca2+ nanocomplex as a novel therapeutic strategy in lung cancer treatment
Ying Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment
Jooho Park et al.
THERANOSTICS (2019)
Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy
Seungho Lim et al.
THERANOSTICS (2019)
Layer-by-Layer Assembly of Heparin and Peptide-Polyethylene Glycol Conjugates to Form Hybrid Nanothin Films of Biomatrices
Alvin Kuriakose Thomas et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Effects of glycol-split low molecular weight heparin on placental, endothelial, and anti-inflammatory pathways relevant to preeclampsia
Jovian M. Wat et al.
BIOLOGY OF REPRODUCTION (2018)
Anticoagulant Properties of Poly(sodium 2-(acrylamido)-2methylpropanesulfonate)-Based Di- and Triblock Polymers
Bartlomiej Kalaska et al.
BIOMACROMOLECULES (2018)
A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours
Keith Dredge et al.
BRITISH JOURNAL OF CANCER (2018)
Phase I study of the heparanase inhibitor roneparstat: an innovative approach for multiple myeloma therapy
Monica Galli et al.
HAEMATOLOGICA (2018)
Self-assembled nanocomplex of PEGylated protamine and heparin-suramin conjugate for accumulation at the tumor site
Jooho Park et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Phase I study of the heparanase inhibitor roneparstat: an innovative approach for multiple myeloma therapy
Monica Galli et al.
HAEMATOLOGICA (2018)
Copper regulates the interactions of antimicrobial piscidin peptides from fish mast cells with formyl peptide receptors and heparin
So Young Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Rivaroxaban versus enoxaparin for the prevention of recurrent venous thromboembolism in patients with cancer A meta-analysis
Jiali Xing et al.
MEDICINE (2018)
Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin
Herbert H. Lipowsky et al.
MICROVASCULAR RESEARCH (2017)
New Applications of Heparin and Other Glycosaminoglycans
Marcelo Lima et al.
MOLECULES (2017)
Heparin Mimetics: Their Therapeutic Potential
Shifaza Mohamed et al.
PHARMACEUTICALS (2017)
A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway
Jeong Uk Choi et al.
BIOMATERIALS (2017)
Recent advances in anticoagulant drug delivery
Jooho Park et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate)
Farzana Alam et al.
BIOMATERIALS (2016)
End-Site-Specific Conjugation of Enoxaparin and Tetradeoxycholic Acid Using Nonenzymatic Glycosylation for Oral Delivery
Jooho Park et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Novel oral anticoagulants and reversal agents: Considerations for clinical development
Troy C. Sarich et al.
AMERICAN HEART JOURNAL (2015)
Advanced Nanocarriers Based on Heparin and Its Derivatives for Cancer Management
Xiaoye Yang et al.
BIOMACROMOLECULES (2015)
Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy
Farzana Alam et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Chemical Conjugate of Low Molecular Weight Heparin and Suramin Fragment Inhibits Tumor Growth Possibly by Blocking VEGF165
Jooho Park et al.
MOLECULAR PHARMACEUTICS (2015)
Inhibition of influenza H5N1 invasion by modified heparin derivatives
Mark A. Skidmore et al.
MEDCHEMCOMM (2015)
Determinants of Glycosaminoglycan (GAG) Structure
Kristian Prydz
BIOMOLECULES (2015)
The new oral anticoagulants: clinical use and reversal agent development
J. Costin et al.
STATE OF THE ART PRESENTATIONS 33RD INTERNATIONAL CONGRESS OF THE INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION, IN CONJUNCTION WITH THE 33RD CONGRESS OF THE KSBT AND 2014 CONGRESS OF THE KOREAN HEMATOLOGY SOCIETIES, VOL 10, NO S1 (2015)
A world of low molecular weight heparins (LMWHs) enoxaparin as a promising moiety-A review
Rahul G. Ingle et al.
CARBOHYDRATE POLYMERS (2014)
Current Developments for the Oral Delivery of Heparin
Anna Schlueter et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2014)
Oral absorption mechanism and anti-angiogenesis effect of taurocholic acid-linked heparin-docetaxel conjugates
Zehedina Khatun et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study
A. Lazo-Langner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Heparin-protein interactions: From affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis
Franck Peysselon et al.
MATRIX BIOLOGY (2014)
Bemiparin, an effective and safe low molecular weight heparin: A review
Marco Matteo Ciccone et al.
VASCULAR PHARMACOLOGY (2014)
An apoptosis-homing peptide-conjugated low molecular weight heparin-taurocholate conjugate with antitumor properties
Sang Mun Bae et al.
BIOMATERIALS (2013)
Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides
Wenjing Zhao et al.
BIOSCIENCE REPORTS (2012)
Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis
Seung Rim Hwang et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
K. Dredge et al.
BRITISH JOURNAL OF CANCER (2011)
Biomimetic Solid Lipid Nanoparticles for Oral Bioavailability Enhancement of Low Molecular Weight Heparin and Its Lipid Conjugates: In Vitro and in Vivo Evaluation
Rishi Paliwal et al.
MOLECULAR PHARMACEUTICS (2011)
Pharmacokinetic evaluation of an oral tablet form of low-molecular-weight heparin and deoxycholic acid conjugate as a novel oral anticoagulant
Jin Woo Park et al.
THROMBOSIS AND HAEMOSTASIS (2011)
High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives
Jin Woo Park et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Semi-Rigid Solution Structures of Heparin by Constrained X-ray Scattering Modelling: New Insight into Heparin-Protein Complexes
Sanaullah Khan et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Anticoagulant Efficacy of Solid Oral Formulations Containing a New Heparin Derivative
Jin Woo Park et al.
MOLECULAR PHARMACEUTICS (2010)
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs
Herve Decousus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor
Esak Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra-low-molecular-weight heparin, AVE5026
C. Viskov et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
Bengt I. Eriksson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Heparin and low-molecular-weight heparin
Elaine Gray et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer
Fikri Icli et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity
Kyeongsoon Park et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation
Daniel J. D. Johnson et al.
EMBO JOURNAL (2006)
Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation
SK Kim et al.
THROMBOSIS RESEARCH (2006)
Evaluation of absorption of heparin-DOCA conjugates on the intestinal wall using a surface plasmon resonance
SK Kim et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2005)
Heparan sulphate proteoglycans:: The sweet side of development
U Häcker et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer
M Altinbas et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
AK Kakkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Challenges for the oral delivery of macromolecules
M Goldberg et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury
J Kim et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2002)
Heparin and heparan sulfate: structure and function
DL Rabenstein
NATURAL PRODUCT REPORTS (2002)
Fondaparinux sodium: A selective inhibitor of factor Xa
KA Bauer
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2001)
Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin
Z Shriver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Treatment of experimentally induced caval thrombosis with oral low molecular weight heparin and delivery agent in a porcine model of deep venous thrombosis
K Salartash et al.
ANNALS OF SURGERY (2000)
分享论文
